Clinical Evaluation of a new Anthelmintic—Thiabendazole [2-(4′-Thiazolyl)-Benzimidazole]

Abstract
Summary Thiabendazole administered to 61 patients with intestinal helminthiasis in single doses of 1.25 or 2.5 grams was found to be effective in Ascaris lumbricoides infection in a dose of 1.25 g. Its action against Ancylostoma duodenale was comparable in effectiveness to 2 g of bephenium or 3 ml of tetrachlorethylene, on the basis of mean percentage reduction in egg-count. It had no marked effect on Trichuris trichiura infection. In a dose of 2.5 g it produced giddiness and vomiting.

This publication has 0 references indexed in Scilit: